Molecular alterations monitoring in myelodysplastic patients receiving an allogeneic hematopoietic stem cell transplantation after a reduced-intensity conditioning regimen

被引：0
|
作者：
Robin, Marie [1 ]
Nibourel, Olivier [2 ]
Tournaire, Martin [3 ]
Michonneau, David [1 ]
Preudhomme, Claude [2 ]
Verbanck, Marie [3 ]
Xhaard, Alienor [1 ]
Ades, Lionel [4 ]
de Fontbrune, Flore Sicre [1 ]
Sebert, Marie [4 ]
Fenaux, Pierre [4 ]
Socie, Gerard [1 ]
de Latour, Regis Peffault [1 ]
Curis, Emmanuel [3 ,5 ]
机构：
[1] Univ Paris Cite, Hop St Louis, Hematol Greffe, Paris, France
[2] Univ Lille, CHU Lille, CANTHER Canc Heterogene Plast & Resistance Therapi, CNRS,Inserm,UMR9020,U1277, F-59000 Lille, France
[3] Univ Paris Cite, Fac Pharm Paris, UR 7537, BioSTM, 4 Ave Observ, F-75014 Paris, France
[4] Univ Paris, Hop St Louis, Hematol, Paris, France
[5] Hop Lariboisiere, AP HP, Lab Hematol, 2 Rue Ambroise Pare, F-75010 Paris, France
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷 / 09期
关键词：
DONOR AVAILABILITY; RESIDUAL DISEASE; LEUKEMIA;
D O I：
10.1038/s41409-024-02314-2
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1309 / 1312
页数：4
相关论文
共 50 条
  • [1] Secondary malignancies after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and outpatient conduction
    Zamora-Ortiz, Gabriela
    Velazquez-Sanchez-de-Cima, Sara
    Ponce-de-Leon, Sergio
    Homero Gutierrez-Aguirre, Cesar
    Jose Ruiz-Delgado, Guillermo
    Gomez-Almaguer, David
    Jose Ruiz-Argueelles, Guillermo
    HEMATOLOGY, 2014, 19 (08) : 435 - 440
  • [2] Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced
    Shimoni, A.
    Shem-Tov, N.
    Chetrit, A.
    Volchek, Y.
    Tallis, E.
    Avigdor, A.
    Sadetzki, S.
    Yerushalmi, R.
    Nagler, A.
    LEUKEMIA, 2013, 27 (04) : 829 - 835
  • [3] Radioimmunotherapy in Combination with Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Multiple Myeloma
    Fasslrinner, Frederick
    Stoelzel, Friedrich
    Kramer, Michael
    Teipel, Raphael
    Brogsitter, Claudia
    Morgner, Anke
    Arndt, Claudia
    Bachmann, Michael
    Haenel, Mathias
    Roellig, Christoph
    Kotzerke, Joerg
    Schetelig, Johannes
    Bornhaeuser, Martin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (04) : 691 - 697
  • [4] Feasibility of Second Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning with Fludarabine and Melphalan after a Failed Autologous Hematopoietic Stem Cell Transplantation
    Hong, J. Y.
    Choi, M. K.
    Kim, D. H.
    Kim, S. J.
    Kim, K.
    Kim, W. S.
    Chung, C. W.
    Kim, H. O.
    Min, Y. H.
    Jang, J. H.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3723 - 3728
  • [5] Impact of Hyperferritinemia on the Outcome of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Lymphoid Malignancies
    Barba, Pere
    Valcarcel, David
    Antonio Perez-Simon, Jose
    Fernandez-Aviles, Francesc
    Luis Pinana, Jose
    Martino, Rodrigo
    Lopez-Anglada, Lucia
    Rovira, Montserrat
    Garcia-Cadenas, Irene
    Novelli, Silvana
    Carreras, Enric
    Lopez Corral, Lucia
    Sierra, Jorge
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (04) : 597 - 601
  • [6] Outcome after Transplantation According to Reduced-Intensity Conditioning Regimen in Patients Undergoing Transplantation for Myelofibrosis
    Robin, Marie
    Porcher, Raphael
    Wolschke, Christine
    de Fontbrune, Flore Sicre
    Alchalby, Haefaa
    Christopeit, Maximilian
    Cassinat, Bruno
    Zabelina, Tatjana
    de Latour, Regis Peffault
    Ayuk, Francis
    Socie, Gerard
    Kroger, Nicolaus
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (07) : 1206 - 1211
  • [7] Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan
    Oran, Betul
    Giralt, Sergio
    Saliba, Rima
    Hosing, Chitra
    Popat, Uday
    Khouri, Issa
    Couriel, Daniel
    Qazilbash, Muzaffar
    Anderlini, Paolo
    Kebriaei, Partow
    Ghosh, Shubhra
    Carrasco-Yalan, Antonio
    de Meis, Ernesto
    Anagnostopoulos, Athanasios
    Donato, Michele
    Champlin, Richard E.
    de Lima, Marcos
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (04) : 454 - 462
  • [8] Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia
    Krejci, Marta
    Doubek, Michael
    Brychtova, Yvona
    Stehlikova, Olga
    Chovancova, Jana
    Tichy, Boris
    Francova, Hana Skuhrova
    Navratil, Milan
    Tomiska, Miroslav
    Horky, Ondrej
    Pospisilova, Sarka
    Mayer, Jiri
    ANNALS OF HEMATOLOGY, 2013, 92 (02) : 249 - 254
  • [9] Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies
    Schneidawind, Dominik
    Federmann, Birgit
    Buechele, Corina
    Helwig, Andrea
    Schmohl, Joerg
    Vogel, Wichard
    Faul, Christoph
    Kanz, Lothar
    Bethge, Wolfgang A.
    ANNALS OF HEMATOLOGY, 2016, 95 (01) : 115 - 124
  • [10] Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myeloma
    El-Cheikh, Jean
    Crocchiolo, Roberto
    Boher, Jean-Marie
    Furst, Sabine
    Stoppa, Anne-Marie
    Ladaique, Patrick
    Faucher, Catherine
    Calmels, Boris
    Castagna, Luca
    Lemarie, Claude
    De Colella, Jean-Marc Schiano
    Coso, Diane
    Bouabdallah, Reda
    Chabannon, Christian
    Blaise, Didier
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 88 (06) : 497 - 503
12345